Other Events ·
Nasdaq notifies Baird Medical of non-compliance with the $1.00 minimum bid price requirement
BDMDBaird Medical Investment Holdings Ltd
On November 2, 2026, Nasdaq notified Baird Medical Investment Holdings Limited that its ordinary shares failed to maintain a minimum closing bid price of $1.00 for 30 consecutive business days, triggering a deficiency under Listing Rule 5550(a)(2). The company has a compliance period until May 3, 2027, to regain compliance by achieving a closing bid price of at least $1.00 for ten consecutive business days. Failure to meet this requirement may result in an additional grace period or delisting proceedings. Baird Medical is a global medical device company specializing in minimally invasive ablation technologies.